Analysts anticipate Nutex Health to report an earnings per share (EPS) of $-5.43.
The market awaits Nutex Health's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
Earnings History Snapshot
In the previous earnings release, the company missed EPS by $1.34, leading to a 26.1% increase in the share price the following trading session.
Here's a look at Nutex Health's past performance and the resulting price change:
Quarter
Q1 2025
Q4 2024
Q3 2024
Q2 2024
EPS Estimate
3.90
-0.12
-0.24
-0.02
EPS Actual
2.56
11.12
-1.72
-0.07
Price Change %
26.0%
52.0%
9.0%
28.000000000000004%
Performance of Nutex Health Shares
Shares of Nutex Health were trading at $96.12 as of August 12. Over the last 52-week period, shares are up 693.26%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
Analyst Observations about Nutex Health
Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Nutex Health.
The consensus rating for Nutex Health is Buy, based on 2 analyst ratings. With an average one-year price target of $262.5, there's a potential 173.1% upside.
Peer Ratings Comparison
The ...
